Nagpal, A.; Needham, K.; Lane, D.J.R.; Ayton, S.; Redvers, R.P.; John, M.; Selistre-de-Araujo, H.S.; Denoyer, D.; Pouliot, N.
Integrin αvβ3 Is a Master Regulator of Resistance to TKI-Induced Ferroptosis in HER2-Positive Breast Cancer. Cancers 2023, 15, 1216.
https://doi.org/10.3390/cancers15041216
AMA Style
Nagpal A, Needham K, Lane DJR, Ayton S, Redvers RP, John M, Selistre-de-Araujo HS, Denoyer D, Pouliot N.
Integrin αvβ3 Is a Master Regulator of Resistance to TKI-Induced Ferroptosis in HER2-Positive Breast Cancer. Cancers. 2023; 15(4):1216.
https://doi.org/10.3390/cancers15041216
Chicago/Turabian Style
Nagpal, Aadya, Kristen Needham, Darius J. R. Lane, Scott Ayton, Richard P. Redvers, Melissa John, Heloisa S. Selistre-de-Araujo, Delphine Denoyer, and Normand Pouliot.
2023. "Integrin αvβ3 Is a Master Regulator of Resistance to TKI-Induced Ferroptosis in HER2-Positive Breast Cancer" Cancers 15, no. 4: 1216.
https://doi.org/10.3390/cancers15041216
APA Style
Nagpal, A., Needham, K., Lane, D. J. R., Ayton, S., Redvers, R. P., John, M., Selistre-de-Araujo, H. S., Denoyer, D., & Pouliot, N.
(2023). Integrin αvβ3 Is a Master Regulator of Resistance to TKI-Induced Ferroptosis in HER2-Positive Breast Cancer. Cancers, 15(4), 1216.
https://doi.org/10.3390/cancers15041216